(19)
(11) EP 2 627 265 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.02.2019 Bulletin 2019/08

(45) Mention of the grant of the patent:
14.11.2018 Bulletin 2018/46

(21) Application number: 11774164.5

(22) Date of filing: 14.10.2011
(51) International Patent Classification (IPC): 
A61B 17/12(2006.01)
(86) International application number:
PCT/US2011/056278
(87) International publication number:
WO 2012/051489 (19.04.2012 Gazette 2012/16)

(54)

OCCLUSION DEVICE FOR BLOCKING FLUID FLOW THROUGH BODILY PASSAGES

OKKLUSIONSVORRICHTUNG ZUM BLOCKIEREN DES FLÜSSIGKEITSFLUSSES DURCH KÖRPERDURCHGÄNGE

DISPOSITIF D'OCCLUSION DESTINÉ À BLOQUER L'ÉCOULEMENT DES FLUIDES DANS DES PASSAGES CORPORELS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.10.2010 US 393624 P
17.06.2011 US 201161498048 P

(43) Date of publication of application:
21.08.2013 Bulletin 2013/34

(73) Proprietors:
  • Cook Medical Technologies LLC
    Bloomington, IN 47404 (US)
  • Oregon Health & Science University
    Portland, OR 97239-3098 (US)

(72) Inventors:
  • SHIRLEY, Brad
    Bloomington IN 47403 (US)
  • RANDOLPH, J., R.
    Bloomington IN 47401 (US)
  • PAVCNIK, Dusan
    Portland OR 97223 (US)
  • KELLER, Frederick
    Portland OR 97201 (US)
  • THEOBALD, Elizabeth
    Bloomington IN 47403 (US)
  • CHAMBERS, Sean
    Bloomington IN 47403 (US)
  • PAUL, Ram
    Bloomington IN 47403 (US)

(74) Representative: Garratt, Peter Douglas et al
Mathys & Squire LLP
The Shard 32 London Bridge Street London SE1 9SG
The Shard 32 London Bridge Street London SE1 9SG (GB)


(56) References cited: : 
WO-A2-2008/094706
US-A1- 2006 009 800
 US-A1- 2002 183 787
US-A1- 2010 030 259
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).